Solventum Corporation (SOLV) Covered Calls

Solventum is a leading global healthcare company that spun off from 3M in 2024 to focus on innovative solutions in medtech and health information systems. The company operates through four primary segments: Medical Surgical, Dental Solutions, Health Information Systems, and Purification and Filtration. With a legacy of over 7,300 patents, Solventum aims to enhance patient outcomes and improve healthcare efficiency worldwide.

You can sell covered calls on Solventum Corporation to lower risk and earn monthly income. Born To Sell's covered call screener gives you customized search capabilities across all possible covered calls but here are a couple of examples for SOLV (prices last updated Thu 4:16 PM ET):

Solventum Corporation (SOLV) Stock Quote
Last Change Bid Ask Volume P/E Market Cap
75.95 -5.54 75.00 81.31 1.3M 9.4 14
Covered Calls For Solventum Corporation (SOLV)
Expiration Strike Call Bid Net Debit Return
If Flat		 Annualized
Return If Flat
Feb 20 75 1.20 80.11 -6.4% -259.6%
Mar 20 75 3.80 77.51 -3.2% -31.6%
Subscribers get access to the full covered call chain, and more features.

Want to make money with covered calls?  Sign Up For A Free Trial

Solventum Corporation is a global healthcare giant that emerged as an independent public entity in 2024 through the spin-off of 3M Company’s healthcare business. Headquartered in St. Paul, Minnesota, Solventum is a diversified medtech leader, leveraging a vast intellectual property portfolio to solve the most difficult challenges at the intersection of material science, digital health, and clinical workflows.

The company’s operations are organized into four mission-critical segments:

  1. Medical Surgical (MedSurg): The largest revenue driver, providing advanced wound care, negative pressure wound therapy, and infection prevention products utilized in millions of treatments annually.
  2. Dental Solutions: A global leader in restorative and orthodontic materials, including the iconic Filtek and Clarity brands, serving practitioners in over 90 countries.
  3. Health Information Systems: Delivering AI-powered software solutions for clinical documentation and revenue cycle management, currently utilized by approximately 75% of U.S. hospitals.
  4. Purification & Filtration: Specialized in high-performance membranes and filters for biopharmaceutical manufacturing and life-saving dialysis treatments.

The competitive landscape for Solventum is defined by large-scale medical device firms and specialized dental or software providers. In the dental and orthodontic space, the company competes directly with Align Technology and Henry Schein. In the medical-surgical and contact lens/filtration segments, it frequently vies for market share against Baxter International and The Cooper Companies. Additionally, the company faces growing competition from healthcare-focused tech giants in the clinical AI and data analytics space.

Strategic Outlook and Innovation

Solventum is currently executing a "Transformation Plan" designed to accelerate organic growth through commercial restructuring and portfolio optimization. A major strategic pillar is the integration of the recently acquired Acera Surgical, which bolsters the company’s advanced wound care capabilities with innovative "synthetic" tissue technologies. Innovation efforts are also focused on the launch of AI-driven diagnostic tools for the dental market and the expansion of autonomous coding features within its Health Information Systems platform to reduce administrative waste in hospitals. By divesting non-core business units, such as its industrial filtration arm, and reinvesting in higher-margin medtech sectors, Solventum intends to improve its financial flexibility and deliver best-in-class clinical solutions that lower the total cost of care while improving patient recovery speeds.